Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-09 Sale | 2024-05-10 4:17 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 100 | $15 | $1,500 | 270,051 (Direct) | View |
| 2024-02-12 Purchase | 2024-02-14 9:06 pm | Mineralys Therapeutics Inc. | MLYS | Samsara BioCapital GP LLC Samsara BioCapital L.P. 10% Owner | 555,555 | $13.5 | $7,499,993 | 5,074,916 (Indirect) | View |
| 2023-11-22 Purchase | 2023-11-27 4:01 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 4,250 | $5.9661 | $25,356 | 1,049,068 (Direct) | View |
| 2023-09-06 Purchase | 2023-09-08 08:49 am | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 2,250 | $12.08 | $27,180 | 1,044,818 (Direct) | View |
| 2023-08-17 Purchase | 2023-08-21 4:03 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 2,250 | $12.1 | $27,225 | 1,042,568 (Direct) | View |
| 2023-08-10 Sale | 2023-08-11 7:11 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 231,716 | $12.92 | $2,994,401 | 480,043 (Direct) | View |
| 2023-08-11 Purchase | 2023-08-11 7:11 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 2,000 | $12.89 | $25,780 | 1,040,318 (Direct) | View |
| 2023-02-14 Purchase | 2023-02-16 9:00 pm | Mineralys Therapeutics Inc. | MLYS | HBM Healthcare Investments (Cayman) Ltd. 10% Owner | 312,500 | $16 | $5,000,000 | 3,218,106 (Direct) | View |
| 2023-02-14 Purchase | 2023-02-16 5:04 pm | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 1,250,000 | $16 | $20,000,000 | 1,311,247 (Indirect) | View |
| 2023-02-14 Purchase | 2023-02-16 4:54 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO, Chief Bus. Off. and Secy. | 6,250 | $16 | $100,000 | 350,811 (Direct) | View |
| 2023-02-14 Purchase | 2023-02-16 4:54 pm | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner | 937,500 | $16 | $15,000,000 | 4,519,361 (Indirect) | View |
| 2023-02-14 Purchase | 2023-02-16 4:54 pm | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 250,000 | $16 | $4,000,000 | 9,194,579 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-22 Option Award | 2024-05-23 4:21 pm | N/A 2034-05-22 | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 22,000 | $0 | 22,000 (Direct) | View |
| 2024-05-22 Option Award | 2024-05-23 4:20 pm | N/A 2034-05-22 | Mineralys Therapeutics Inc. | MLYS | Litzka Olivier Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2024-05-13 Exercise | 2024-05-15 4:43 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $0 | 315,207 (Direct) | View |
| 2024-05-13 Exercise | 2024-05-15 4:43 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 315,207 (Direct) | View |
| 2024-05-13 Exercise | 2024-05-15 4:43 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,018 | $0.54 | 315,207 (Direct) | View |
| 2024-05-09 Exercise | 2024-05-10 4:17 pm | N/A 2031-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 100 | $0 | 270,051 (Direct) | View |
| 2024-05-09 Exercise | 2024-05-10 4:17 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 100 | $1.08 | 270,051 (Direct) | View |
| 2024-04-11 Exercise | 2024-04-15 4:24 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $0 | 315,307 (Direct) | View |
| 2024-04-12 Exercise | 2024-04-15 4:24 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 315,307 (Direct) | View |
| 2024-04-11 Exercise | 2024-04-15 4:24 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 315,307 (Direct) | View |
| 2024-03-11 Exercise | 2024-03-13 5:35 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,365 | $0 | 315,307 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-13 5:35 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 315,307 (Direct) | View |
| 2024-03-11 Exercise | 2024-03-13 5:35 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 315,307 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 4:26 pm | N/A 2034-02-13 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 4:26 pm | N/A 2034-02-13 | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 4:26 pm | N/A 2034-02-13 | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 425,000 | $0 | 425,000 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 9:07 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Director 10% Owner | 555,555 | $13.5 | 5,074,916 (Indirect) | View |
| 2024-02-12 Option Award | 2024-02-14 7:49 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 1,672,508 | $13.5 | 5,400,739 (Indirect) | View |
| 2024-02-12 Option Award | 2024-02-14 7:49 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 549,755 | $13.5 | 5,400,739 (Indirect) | View |
| 2024-02-12 Exercise | 2024-02-13 4:08 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $0 | 315,307 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-13 4:08 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 315,307 (Direct) | View |
| 2024-02-12 Exercise | 2024-02-13 4:08 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 315,307 (Direct) | View |
| 2024-01-11 Exercise | 2024-01-12 4:01 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,365 | $0 | 315,307 (Direct) | View |
| 2024-01-12 Exercise | 2024-01-12 4:01 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 315,307 (Direct) | View |
| 2024-01-11 Exercise | 2024-01-12 4:01 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 315,307 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-12 5:08 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,018 | $0 | 85,293 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-12 5:08 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,018 | $0.54 | 85,293 (Direct) | View |
| 2023-11-13 Exercise | 2023-11-14 6:18 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0 | 85,293 (Direct) | View |
| 2023-11-13 Exercise | 2023-11-14 6:18 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 85,293 (Direct) | View |
| 2023-11-03 Exercise | 2023-11-07 5:15 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 10,034 | $0 | 85,293 (Direct) | View |
| 2023-11-03 Exercise | 2023-11-07 5:15 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 10,034 | $0.54 | 85,293 (Direct) | View |
| 2023-09-13 Option Award | 2023-09-14 4:13 pm | N/A 2033-09-13 | Mineralys Therapeutics Inc. | MLYS | Karydas Daphne Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2023-09-13 Option Award | 2023-09-14 4:13 pm | N/A 2033-09-13 | Mineralys Therapeutics Inc. | MLYS | SBLENDORIO GLENN Director | 44,000 | $0 | 44,000 (Direct) | View |
| 2023-08-10 Exercise | 2023-08-11 7:11 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 231,716 | $0 | 480,043 (Direct) | View |
| 2023-08-11 Exercise | 2023-08-11 7:11 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 76,182 | $1.08 | 480,043 (Direct) | View |
| 2023-08-10 Exercise | 2023-08-11 7:11 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 155,534 | $0.54 | 480,043 (Direct) | View |
| 2023-07-12 Other | 2023-07-14 08:55 am | N/A 2033-02-09 | Mineralys Therapeutics Inc. | MLYS | Takahashi Takeshi Director | 44,000 | $0 | 0 (Direct) | View |
| 2023-07-12 Other | 2023-07-14 08:55 am | N/A 2033-02-09 | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 132,000 | $0 | 88,000 (Direct) | View |
| 2023-04-27 Other | 2023-05-01 4:06 pm | N/A 2033-02-09 | Mineralys Therapeutics Inc. | MLYS | Litzka Olivier Director | 44,000 | $0 | 0 (Direct) | View |
| 2023-03-17 Option Award | 2023-03-21 6:48 pm | N/A 2033-03-17 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-03-17 Option Award | 2023-03-21 6:48 pm | N/A 2033-03-17 | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 99,800 | $0 | 99,800 (Direct) | View |
| 2023-03-17 Option Award | 2023-03-21 6:47 pm | N/A 2033-03-17 | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-02-14 Conversion | 2023-02-16 9:00 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | HBM Healthcare Investments (Cayman) Ltd. 10% Owner | 34,280,347 | $0 | 3,218,106 (Direct) | View |
| 2023-02-14 Conversion | 2023-02-16 5:04 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 1,928,476 | $0 | 1,311,247 (Indirect) | View |
| 2023-02-14 Conversion | 2023-02-16 4:54 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner | 7,163,722 | $0 | 4,519,361 (Indirect) | View |
| 2023-02-14 Conversion | 2023-02-16 4:54 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 8,628,186 | $0 | 9,194,579 (Indirect) | View |
| 2023-02-09 Option Award | 2023-02-13 9:13 pm | N/A 2023-02-09 | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 44,000 | $0 | 44,000 (Indirect) | View |
| 2023-02-09 Option Award | 2023-02-13 9:03 pm | N/A 2033-02-09 | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 44,000 | $0 | 44,000 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 9:03 pm | N/A 2033-02-09 | Mineralys Therapeutics Inc. | MLYS | DiRocco Derek Director | 44,000 | $0 | 44,000 (Direct) | View |